Search results for "Follicular Fluid"

showing 8 items of 8 documents

66 RELATIONSHIP BETWEEN PLASMA CHLORIDE LEVELS AND FOLLICLE DIAMETER IN CYCLING SPANISH PUREBRED MARES

2014

Several studies in cows have shown that plasma levels of chloride are positively correlated with the diameter of the preovulatory follicle (FD), establishing at the same time a significant positive association between plasma levels and intraoviducal concentration of this electrolyte (Hugentobler et al. 2007). These relationships may reflect the influence of changes in systemic metabolic plasma on follicular fluid, physiological events that might be closely related to the quality of the oocyte and granulosa cells of the preovulatory follicle (LeRoy et al. 2004). However, these mechanisms remain unknown in the mare. The objective of this research was to investigate the relationship between p…

medicine.medical_specialtymedia_common.quotation_subjectReproductive technologyBiologyFollicular fluidChlorideAndrologyFollicleEndocrinologyEndocrinologyReproductive MedicineInternal medicineFollicular phaseGeneticsmedicineAnimal Science and ZoologyFolliculogenesisMolecular BiologySpermatogenesisOvulationDevelopmental BiologyBiotechnologymedicine.drugmedia_commonReproduction, Fertility and Development
researchProduct

Let's rescue oocytes: in vitro maturation 2.0 is coming

2018

Cumulus Cells030219 obstetrics & reproductive medicineObstetrics and Gynecology030209 endocrinology & metabolismBiologyFollicular FluidCell biologyIn vitro maturation03 medical and health sciences0302 clinical medicineReproductive MedicineOocytesHumansFemalePolycystic Ovary SyndromeFertility and Sterility
researchProduct

The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic?

2012

STUDY QUESTION What is the final hormonal milieu of pre-ovulatory follicles of low-responder (LR) patients undergoing unstimulated cycles? SUMMARY ANSWER Neither androgen secretion nor LH was impaired in pre-ovulatory follicles of LR women. WHAT IS KNOWN ALREADY Therapies currently used to improve ovarian response in LR women have an impact on the final hormonal follicular milieu, and these changes are believed to be partially responsible for determining the success rate in these women. Surprisingly, as far as we know, there is no report of the final hormonal profile of LR women undergoing unstimulated cycles or evidence that follicular androgen secretion in LR women is impaired. STUDY DESI…

Adultmedicine.medical_specialtymedicine.drug_classDrug ResistanceFertilization in VitroSpindle ApparatusBiologyOvarian FollicleOvulation InductionInternal medicineFollicular phasemedicineHumansProspective StudiesOvarian follicleTestosterone CongenersMetaphaseProgesteroneTestosteroneOocyte DonationRehabilitationAge FactorsObstetrics and GynecologyFertility Agents FemaleLuteinizing HormoneAntral follicleAndrogenFollicular fluidFollicular FluidAndrogen secretionEndocrinologymedicine.anatomical_structureFollicular PhaseReproductive MedicineCase-Control StudiesOocytesFemaleFollicle Stimulating HormoneInfertility FemaleHormoneHuman Reproduction
researchProduct

Oxidative homeostasis in follicular fluid and reproductive outcomes – from bench to bedside

2022

Free radicals and oxidant molecules are part of our organism in a stable balance. However, when addressing female infertility, questions about their role in oocyte quality arise. This review outlines the major alterations of redox homeostasis in the follicular fluid through pathophysiological conditions in female reproduction and its potential effect on IVF outcome. A review of the literature was accurately performed. Manuscripts investigating follicular fluid biomarkers, especially related to oxidant molecules, were screened and used in this review. Studies assessing the follicular reactive species were found and screened. Moreover, studies assessing the IVF outcomes related to biomarkers …

OxidantIn vitro fertilizationEndocrinology Diabetes and MetabolismAssisted reproductive techniqueObstetrics and GynecologyFollicular fluidReactive-oxygen species.Settore MED/40 - Ginecologia E OstetriciaMenopausal Review
researchProduct

Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes

2016

Background Follicular fluid (FF) is an important micro-environment influencing oocyte growth, its development competence, and embryo viability. The FF content analysis allows to identify new relevant biomarkers, which could be predictive of in vitro fertilization (IVF) outcomes. Inside ovarian follicle, the amount of FF components from granulosa cells (GC) secretion, could be regulated by gonadotropins, which play a major role in follicle development. Methods This prospective study included 61 female undergoing IVF or Intra-cytoplasmic sperm injection (ICSI) procedure. Apolipoprotein B (APOB) concentrations in follicular fluid and APOB gene and protein expression in granulosa cells from rep…

0301 basic medicineApolipoprotein Bmedicine.medical_treatment[SDV]Life Sciences [q-bio]Human follicular fluidOocyte RetrievalChorionic GonadotropinHuman chorionic gonadotropinFollicle-stimulating hormone0302 clinical medicineEndocrinologyProspective Studies030219 obstetrics & reproductive medicinebiologyObstetrics and Gynecology[SDV] Life Sciences [q-bio]Treatment Outcomemedicine.anatomical_structureFemalelipids (amino acids peptides and proteins)Apolipoprotein BEmbryo qualityAdultmedicine.medical_specialtyendocrine systemEmbryonic DevelopmentFertilization in Vitro03 medical and health sciencesOvulation InductionInternal medicinemedicineIVF outcomesHumansOvarian follicleApolipoproteins BHuman granulosa cellsGranulosa CellsIn vitro fertilisation[ SDV ] Life Sciences [q-bio]ResearchEmbryo MammalianOocyteFollicular fluidFollicular Fluid030104 developmental biologyEndocrinologyReproductive MedicineFertilizationbiology.proteinFollicle Stimulating HormoneBiomarkersGonadotropinsDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct

NMR metabolic profile of human follicular fluid.

2010

The environment of the oocyte during its in vivo maturation consists of follicular fluid (FF) and is surrounded by granulosa cells. The FF is derived from the sanguineous plasma and secretions, synthesised in the follicle wall, that contain a large variety of growth factors, cytokines, amino acids, and other metabolites. These metabolites are presumably involved in the physiology of the oocyte. The identification, quantification and study of FF metabolites can provide additional information about the oocyte state which can be helpful in distinguishing those oocytes that have a greater capacity to be fertilised and to develop properly. The aim of this work is to identify the metabolic profil…

AdultMagnetic Resonance SpectroscopyAdolescentmedicine.medical_treatmentBiologyFollicleYoung AdultMetabolomicsmedicineMetabolomeHumansRadiology Nuclear Medicine and imagingSpectroscopyFertilisationIn vitro fertilisationOocyteFollicular fluidTissue DonorsFollicular FluidMetabolic pathwaymedicine.anatomical_structureBiochemistryMetabolomeMolecular MedicineFemaleMetabolic Networks and PathwaysNMR in biomedicine
researchProduct

Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cy…

2012

background: The use of ovarian stimulation, to stimulate a multi-follicular response for assisted reproduction treatments, may force the production of oocytes from follicles that do not reach optimal maturation, possibly yielding oocytes that are not fully competent. The present study aimed to define the follicular environment and oocyte competence of unstimulated pre-ovulatory follicles, to compare it with that of similar-sized stimulated follicles. For this purpose, we analyzed the follicular hormonal milieu, the oocyte meiotic spindle, the embryo development and the cumulus cells gene expression (GE) profiles. methods and results: The study population was divided in two groups: (i) 42 oo…

Adultmedicine.medical_specialtymedia_common.quotation_subjectGene ExpressionBiologyOvarian FollicleOvulation InductionInternal medicineFollicular phasemedicineHumansTestosteroneRNA MessengerSperm Injections IntracytoplasmicOvarian follicleOvulationProgesteronemedia_commonCumulus CellsEstradiolReverse Transcriptase Polymerase Chain ReactionRehabilitationAndrostenedioneObstetrics and GynecologyEmbryoLuteinizing HormoneEmbryo MammalianMicroarray AnalysisOocyteFollicular fluidCumulus oophorusHormonesFollicular FluidMeiosismedicine.anatomical_structureEndocrinologyReproductive MedicineOocytesFemaleFolliculogenesisFollicle Stimulating HormoneHuman Reproduction
researchProduct

Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.

2021

Objective To compare ovarian response and reproductive outcomes in oocyte donors undergoing pituitary suppression with medroxyprogesterone acetate (MPA) versus those undergoing conventional treatment with a gonadotropin-releasing hormone (GnRH) antagonist. Design A prospective, randomized, controlled trial of cycles was conducted from October 2017 to June 2019 to evaluate ovarian response in terms of the number of oocytes. The reproductive outcomes of the recipients were retrospectively analyzed later. Setting A university-affiliated private in vitro fertilization center. Patient(s) We randomly divided 318 donors into 2 groups in a 1:1 ratio. The oocytes obtained were assigned to 364 recipi…

0301 basic medicineAdultmedicine.drug_classmedia_common.quotation_subjectMedroxyprogesterone AcetateGonadotropin-releasing hormone antagonistAndrologyGonadotropin-Releasing Hormone03 medical and health sciences0302 clinical medicineOvulation InductionPregnancyFollicular phasemedicineMedroxyprogesterone acetateHumansProspective StudiesGanirelixOvulationmedia_common030219 obstetrics & reproductive medicineEstradiolOocyte Donationbusiness.industryAntagonistObstetrics and GynecologyLuteinizing HormoneMiddle AgedFollicular fluid030104 developmental biologyReproductive MedicineFemaleLuteinizing hormonebusinessmedicine.drugFertility and sterility
researchProduct